Literature DB >> 6892753

Primary mediastinal lymphoma in adults.

A K Lichtenstein, A Levine, C R Taylor, W Boswell, S Rossman, D I Feinstein, R J Lukes.   

Abstract

The incidence of primary mediastinal lymphoma in adults was investigated in 184 patients with non-Hodgkin's lymphoma. This entity was defined as disease within the mediastinum in patients who presented with symptoms due to an enlarging mediastinal mass. Of 184 patients, 17 presented with primary mediastinal lymphoma. All had a diffuse histologic pattern. The most common pathologic type was poorly differentiated lymphocytic lymphoma, diffuse (PDL-D), (11 cases). In nine of these 11 cases the patients had tumors of convoluted lymphocytes. The presentation was rapid in onset, with heart failure, pericarditis, dyspnea and superior vena caval syndrome predominating. Eleven of the 17 were clinical stage I or II, but eight of these had widespread disease on pathologic staging or rapid dissemination soon after diagnosis. In conclusion (1) primary mediastinal lymphoma is always diffuse in histology. (2) The most frequent pathologic type is PDL-D, with convoluted morphology. (3) Compression of vital intra-thoracic structures is common. (4) Although seemingly localized at presentation, this entity usually implies disseminated disease.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6892753     DOI: 10.1016/0002-9343(80)90294-6

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  16 in total

Review 1.  Tumours of the thymus and their nomenclature.

Authors:  H F Otto
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  Primary mediastinal DLBCL: evolving biologic understanding and therapeutic strategies.

Authors:  Pier Luigi Zinzani; Pier Paolo Piccaluga
Journal:  Curr Oncol Rep       Date:  2011-10       Impact factor: 5.075

Review 3.  Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?

Authors:  Cliona Grant; Kieron Dunleavy; Franziska C Eberle; Stefania Pittaluga; Wyndham H Wilson; Elaine S Jaffe
Journal:  Curr Hematol Malig Rep       Date:  2011-09       Impact factor: 3.952

4.  Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant.

Authors:  Santosha Vardhana; Paul A Hamlin; Joanna Yang; Andrew Zelenetz; Craig S Sauter; Matthew J Matasar; Andy Ni; Joachim Yahalom; Craig H Moskowitz
Journal:  Biol Blood Marrow Transplant       Date:  2018-06-15       Impact factor: 5.742

5.  Gray zones around diffuse large B cell lymphoma. Conclusions based on the workshop of the XIV meeting of the European Association for Hematopathology and the Society of Hematopathology in Bordeaux, France.

Authors:  Leticia Quintanilla-Martinez; Daphne de Jong; Antoine de Mascarel; Eric D Hsi; Philip Kluin; Yaso Natkunam; Marie Parrens; Stefano Pileri; German Ott
Journal:  J Hematop       Date:  2009-12-22       Impact factor: 0.196

6.  Adhesion receptor profile of thymic B-cell lymphoma.

Authors:  A Eichelmann; K Koretz; G Mechtersheimer; P Möller
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

7.  Childhood B cell lymphomas arising in the mediastinum.

Authors:  T F Carr; L Lockwood; R F Stevens; P H Morris-Jones; I Lewis; P E DaCosta; A M Kelsey
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

Review 8.  Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?

Authors:  Kieron Dunleavy; Cliona Grant; Franziska C Eberle; Stefania Pittaluga; Elaine S Jaffe; Wyndham H Wilson
Journal:  Curr Hematol Malig Rep       Date:  2012-09       Impact factor: 3.952

9.  Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulins.

Authors:  Stefano A Pileri; Gianluca Gaidano; Pier Luigi Zinzani; Brunangelo Falini; Philippe Gaulard; Emanuele Zucca; Federica Pieri; Eva Berra; Elena Sabattini; Stefano Ascani; Milena Piccioli; Peter W M Johnson; Roberto Giardini; Edoardo Pescarmona; Domenico Novero; Pier Paolo Piccaluga; Teresa Marafioti; Miguel A Alonso; Franco Cavalli
Journal:  Am J Pathol       Date:  2003-01       Impact factor: 4.307

10.  Unusual cyclin D1 positive marginal zone lymphoma of mediastinum.

Authors:  Grzegorz Rymkiewicz; Konrad Ptaszyński; Jan Walewski; Katarzyna Błachnio; Pawel Swoboda; Monika Gos; Ewa Paszkiewicz-Kozik; Renata Woroniecka; Barbara Pieńkowska-Grela; Małgorzata Czarnocka; Przemysław Janik
Journal:  Med Oncol       Date:  2006       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.